Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis

Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis

© 2016 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd Background and Aim: Chronic hepatitis C is an important public health problem in Asia. We evaluated the safety, efficacy, and pharmacokinetics of fixed-dose ritonavir-boosted danoprevir plus pegin...

Saved in:

書目詳細資料
Main Authors:	Kao J., Tung S., Lee Y., Thongsawat S., Tanwandee T., Sheen I., Wu J., Li H., Brennan B., Zhou J., Le Pogam S., Najera I., Thommes J., Hill G.
格式:	雜誌
出版:	2017
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85002152541&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/41509
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	Chiang Mai University

相似書籍

Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis
由: Jia Horng Kao, et al.
出版: (2018)

THE DYNAMICS FOR ANTI-HBV INFECTION TREATMENT WITH PEGINTERFERON ALFA-2A
由: VIRA AKMERIANA (NIM: 10108054) ; Pembimbing : Dr. Nuning Nuraini,

Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin
由: G. R. Foster, et al.
出版: (2018)

Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin
由: G. R. Foster, et al.
出版: (2018)

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
由: Lau G.K.K., et al.
出版: (2014)

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
由: George K.K. Lau, et al.
出版: (2018)

Serum proteins in chronic hepatitis B patients treated with peginterferon alfa-2b
由: Sunida Kuakarn, et al.
出版: (2018)

Kombinasi interferon alfa-2b dengan ribavirin untuk terapi penderita hepatitis C kronik yang naive
由: Perpustakaan UGM, i-lib
出版: (2006)

Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C
由: Y. F. Liaw, et al.
出版: (2018)

Molecular Mechanisms of Interferon Resistance Mediated by NS3, NS4A and NS4B Genes of Hepatitis C Viruses in Chronic Hepatitis C Patients Treated with Peginterferon-α and Ribavirin
由: Pattranuch Chusri
出版: (2020)

Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study
由: Charatcharoenwitthaya P., et al.
出版: (2017)

Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study
由: Phunchai Charatcharoenwitthaya, et al.
出版: (2018)

Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study
由: Phunchai Charatcharoenwitthaya, et al.
出版: (2018)

Incidence and Characteristic of Hepatocellular Carcinoma in Hepatitis B Related Cirrhosis
由: Supot Nimanong, et al.
出版: (2020)

Effect of dietary purines on the pharmacokinetics of orally administered ribavirin
由: Li, L., et al.
出版: (2011)

Effect of D168V mutation in NS3/4A HCV protease on susceptibilities of faldaprevir and danoprevir
由: Arthitaya Meeprasert, et al.
出版: (2018)

Effect of D168V mutation in NS3/4A HCV protease on susceptibilities of faldaprevir and danoprevir
由: Meeprasert A., et al.
出版: (2017)

Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: Safety and pharmacokinetics
由: Seo, S., et al.
出版: (2016)

Primary biliary cirrhosis - An uncommon disease in Singapore
由: Yap, I., et al.
出版: (2016)

Peptic ulcer in hepatic cirrhosis and renal failure.
由: Kang, J.Y.
出版: (2014)

Efficacy of pegylated interferon and ribavirin for the treatment of chronic hepatitis C, genotype 3 patients in Thailand
由: Watcharasak Chotiyaputta, et al.
出版: (2019)

Serum lactate levels in cirrhosis and non-cirrhosis patients with septic shock
由: Surat Tongyoo, et al.
出版: (2022)

Serum lactate levels in cirrhosis and non-cirrhosis patients with septic shock
由: Tongyoo S.
出版: (2023)

A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients
由: Jintanat Ananworanich, et al.
出版: (2018)

Inhibition of dengue virus replication by mycophenolic acid and ribavirin
由: Ratree Takhampunya, et al.
出版: (2018)

Tocilizumab for treating severe COVID-19 pneumonia refractory to combined hydroxychloroquine, lopinavir plus ritonavir, and favipiravir: A case series
由: Manoon Surabotsophon, et al.
出版: (2020)

Nonresponse to Interferon-? Based Treatment for Chronic Hepatitis C Infection Is Associated with Increased Hazard of Cirrhosis
由: Cozen M.L., et al.
出版: (2019)

Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: Safety and pharmacokinetics
由: Sachiko Seo, et al.
出版: (2018)

Nutritional anaemia in cirrhosis of the liver
由: S. Areekul, et al.
出版: (2018)

THE ROLE OF NITRIC OXIDE IN LIVER CIRRHOSIS
由: WEI CHANGLI
出版: (2019)

Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A
由: Thidarath Rattanaburee, et al.
出版: (2018)

Analysis of mutations in the core and NS5A genes of hepatitis C virus in non-responder and relapser patients after treatment with Peg-IFN-α and ribavirin
由: Kumthip K., et al.
出版: (2017)

Environment and primary biliary cirrhosis: Electrophilic drugs and the induction of AMA
由: Patrick S.C. Leung, et al.
出版: (2018)

Analysis of mutations in the core and NS5A genes of hepatitis C virus in non-responder and relapser patients after treatment with Peg-IFN-α and ribavirin
由: Kattareeya Kumthip, et al.
出版: (2018)

Hepatitis c virus network based classification of hepatocellular cirrhosis and carcinoma
由: Huang, T., et al.
出版: (2014)

Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy
由: Ahizechukwu C. Eke, et al.
出版: (2020)

Pharmacokinetics of esomeprazole in Thai patients with liver cirrhosis
由: Kanlayanee Archasantisuk
出版: (2006)

Impact of liver cirrhosis on nutritional and immunological status
由: Abhasnee Sobhonslidsuk, et al.
出版: (2018)

Nutritional assessment in various stages of liver cirrhosis
由: Chulaporn Roongpisuthipong, et al.
出版: (2018)

Heterogeneous IgA glomerulonephropathy in liver cirrhosis
由: Sinniah, R.
出版: (2012)